D. E. Shaw & Co., Inc.

Position in NRIX — Nurix Therapeutics, Inc.

CIK 1009207 New York, NY

Position in NRIX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,477,207

-$857,939 QoQ

Shares Held

184,551

-46.4% QoQ

Ownership

0.178%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#64

of 210 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. NRIX ranks #98 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,877,959	$626,707,987
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,104,109	$332,369,932
3	EXEL	Exelixis, Inc.	5,551,747	$302,070,554
4	BBIO	BridgeBio Pharma, Inc.	3,633,007	$270,586,360
5	TGTX	Tg Therapeutics, Inc.	3,400,808	$186,840,390
6	HALO	Halozyme Therapeutics, Inc.	2,006,479	$157,047,110
7	AXSM	Axsome Therapeutics, Inc.	604,753	$148,025,391
8	PTCT	Ptc Therapeutics, Inc.	1,548,919	$126,345,322

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,477,207	184,551	-46.4%	Shares	Defined	2026-08-14
2026-03-31	$5,335,146	344,203	+474.4%	Shares	Defined	2026-05-15
2025-03-31	$711,885	59,923	-46.9%	Shares	Defined	2025-05-15
2024-12-31	$2,125,924	112,841	+54.9%	Shares	Defined	2025-02-14
2024-09-30	$1,636,714	72,840	+187.2%	Shares	Defined	2024-11-14
2023-09-30	$199,313	25,358	-50.8%	Shares	Defined	2023-11-14
2023-06-30	$514,504	51,502	-12.8%	Shares	Defined	2023-08-14
2023-03-31	$524,248	59,037	-35.6%	Shares	Defined	2023-05-15
2022-12-31	$1,006,964	91,709	+52.8%	Shares	Defined	2023-02-14
2022-09-30	$781,982	60,014	+149.9%	Shares	Defined	2022-11-14
2021-06-30	$637,038	24,012	-41.7%	Shares	Defined	2021-08-16
2021-03-31	$1,280,845	41,198	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.